Metabolic profiling of human gliomas assessed with NMR
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Jung Eun | - |
dc.contributor.author | Jeun, Sin Soo | - |
dc.contributor.author | Kim, Se Hoon | - |
dc.contributor.author | Yoo, Chang Young | - |
dc.contributor.author | Baek, Hyeon-Man | - |
dc.contributor.author | Yang, Seung Ho | - |
dc.date.available | 2020-02-27T02:21:44Z | - |
dc.date.created | 2020-02-04 | - |
dc.date.issued | 2019-10 | - |
dc.identifier.issn | 0967-5868 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/943 | - |
dc.description.abstract | Little is known about the underlying metabolic alterations of gliomas. The objective of this study was to analyze metabolomic profiles of gliomas diagnosed according to revised WHO classification to demonstrate metabolic signatures beyond isocitrate dehydrogenase (IDH) 1/2 mutation. H-1 NMR spectroscopy of tumor extracts was performed to analyze brain tumor metabolism. We detected 46 metabolites including 2-hydroxyglutarate from human brain tumors. Metabolic profiles obtained were analyzed using multivariate analysis and MetaboAnalyst 3.0, a pathway analysis tool. We found that lactate, glutamate, alanine, glutamine, 2-hydroxglutarate, serine, O-phosphocholine, glycine, glycerol, myo-inositol, aspartate, leucine, threonine, creatine, and valine had top-ranked VIP scores in metabolic pathway analyses of glioma. Major metabolism pathways perturbed in glioma included alanine/aspartate/glutamate metabolism, glycine/serine/threonine metabolism, pyruvate metabolism, taurine/hypotaurine metabolism, and D-glutamine/D-glutamate metabolism. Altered metabolites were defined between low-grade and high-grade gliomas. We identified metabolomics signatures of gliomas associated with 2-hydroxglutarate and glioma grade. Metabolic approach may lead to metabolomic cluster-precision strategy and development of metabolic anti-glioma therapy in the future. (C) 2019 Published by Elsevier Ltd. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCI LTD | - |
dc.relation.isPartOf | JOURNAL OF CLINICAL NEUROSCIENCE | - |
dc.subject | IDH1 | - |
dc.subject | GLUTAMATE | - |
dc.subject | GLYCOLYSIS | - |
dc.subject | TUMORS | - |
dc.title | Metabolic profiling of human gliomas assessed with NMR | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000486093600047 | - |
dc.identifier.doi | 10.1016/j.jocn.2019.07.078 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CLINICAL NEUROSCIENCE, v.68, pp.275 - 280 | - |
dc.identifier.scopusid | 2-s2.0-85070254880 | - |
dc.citation.endPage | 280 | - |
dc.citation.startPage | 275 | - |
dc.citation.title | JOURNAL OF CLINICAL NEUROSCIENCE | - |
dc.citation.volume | 68 | - |
dc.contributor.affiliatedAuthor | Baek, Hyeon-Man | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Glioma | - |
dc.subject.keywordAuthor | Metabolomics | - |
dc.subject.keywordAuthor | Nuclear magnetic resonance | - |
dc.subject.keywordAuthor | 2-Hydroxyglutarate | - |
dc.subject.keywordPlus | IDH1 | - |
dc.subject.keywordPlus | GLUTAMATE | - |
dc.subject.keywordPlus | GLYCOLYSIS | - |
dc.subject.keywordPlus | TUMORS | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.